Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Keck Medicine of University of Southern California
USC Healthcare Center 41450 San Pablo Street, Suite 5100
Los Angeles, California, United States
Phone Web
At Keck Medicine of University of Southern California, we work to lead the way in diagnosing and managing diseases of the thyroid and parathyroid gland. Our team of surgeons, endocrinologists, radiologists, pathologists and nurses provide the highest quality care using the most advanced technology available.
Patients dealing with thyroid disease may face hormonal and metabolic symptoms such as weight gain or loss, fatigue, digestive problems and joint pain. Our team will work with you to determine the best thyroid treatment for your individual needs, which may include surgery.
We offer a comprehensive, multidisciplinary approach to treating thyroid disorders. Our high-volume practice ensures that you receive treatment from the most experienced thyroid surgeons available. We use technologies such as genetic testing to individualize your treatment plan. Our surgeons have expertise in minimally invasive techniques and specialized imaging techniques that lead to shorter surgeries, faster recovery, higher success rates — and more satisfied patients.
Related Content
-
Sensitivity and Responsiveness of the Patient-Reported TED-QOL to Rehabilitative Surgery in Thyroid Eye DiseaseWe tested the sensitivity and responsive...
-
The British Thyroid FoundationThe British Thyroid Foundation (BTF) is ...
-
Mark L. Malton, MDDr. Malton is certified by The American ...
-
Advances in Treatment of Active, Moderate-To-Severe Graves’ OphthalmopathyGraves' ophthalmopathy is defined as aut...
-
The Days After Thyroid Surgery: Pediatric Thyroid Center at CHOP (Part 5 of 9)https://www.youtube.com/watch?v=GUF2vwLB...
-
Efficacy of B-cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves’ Orbitopa...Background: Preliminary studies have sh...
-
Horizon Therapeutics plc Reports Strong Third-Quarter 2019 ResultsHorizon Therapeutics plc today announced...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.